Rifaximin

Rifaximin is a pharmaceutical-grade active ingredient classified as a Non-Absorbable Rifamycin Antibiotic. Mediocon Inc supplies high-purity Rifaximin API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Rifaximin is a semi-synthetic, non-systemic rifamycin-derived antibiotic that acts locally in the gastrointestinal tract. Due to its minimal systemic absorption, it provides targeted antimicrobial activity against gram-positive and gram-negative bacteria in the gut. It is used for traveler's diarrhea, hepatic encephalopathy, and irritable bowel syndrome with predominant diarrhea.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Traveler's diarrhea (non-invasive E. coli)
• Hepatic encephalopathy prevention and treatment
• Irritable bowel syndrome with diarrhea (IBS-D)
• Small intestinal bacterial overgrowth (SIBO)

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings